https://ift.tt/2XlmZsi support@endlesssupplies.biz (Endless Supplies .Biz) February 25, 2019 at 01:02AM
Monday, February 25, 2019
Novartis licenses rights to RNA-targeting cardio drug from Ionis
Swiss drugmaker Novartis said on Monday it is exercising its option to license rights to an investigational, RNA-targeting cardiovascular drug from Ionis Pharmaceuticals as it targets inherited factors that have defied other treatments.
https://ift.tt/2XlmZsi support@endlesssupplies.biz (Endless Supplies .Biz) February 25, 2019 at 01:02AM
https://ift.tt/2XlmZsi support@endlesssupplies.biz (Endless Supplies .Biz) February 25, 2019 at 01:02AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment